[{"Assets_0_Q2_USD":326984000.0,"CommonStockSharesOutstanding_0_Q2_shares":36337542.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-45786000.0,"NetIncomeLoss_1_Q2_USD":-28433000.0,"NetIncomeLoss_2_Q2_USD":-54220000.0,"StockholdersEquity_0_Q2_USD":185042000.0,"Ticker":"AERI","CIK":"1337553","name":"AERIE PHARMACEUTICALS INC","OfficialName":"Aerie Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"408427417.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170803"}]